![医薬と食の融合](/img/pharma+foods.jpg)
With a mission of developing products as effective as pharmaceuticals, we strive to create food ingredients with clear functions that promote Health Maintenance and Quality of Life.
News
2024-06-28
Investor
A milestone has been achieved as set forth in an Exclusive Licensing Agreement between PFI and Mitsubishi Tanabe Pharma Corporation for a New Investigational Therapeutic Antibody for autoimmune diseases
2024-06-11
Investor
(Delayed)Summary of Consolidated Financial Results for the Nine Months Ended April 30, 2024 (Based on Japanese GAAP)
2024-05-28
Investor
Company Research And Analysis Report(FISCO)
2024-03-15
Investor
(Delayed)Summary of Consolidated Financial Results for the Six Months Ended January 31, 2024 (Based on Japanese GAAP)
2024-01-16
Investor
Company Research And Analysis Report(FISCO)
2023-09-29
Investor
Notice of the 26th Annual General Meeting of Shareholders
2023-05-26
Investor
Company Research And Analysis Report(FISCO)
2022-12-07
Investor
Summary of Consolidated Financial Results for the Three Months Ended October 31, 2022 (Based on Japanese GAAP)
2022-12-06
Investor
COMPANY RESEARCH AND ANALYSIS REPORT(FISCO)
2022-09-07
Investor
Summary of Consolidated Financial Results for the Year Ended July 31, 2022 (Based on Japanese GAAP)
More
![](/img/pdficon_small.png)
![](/img/pdficon_small.png)
![](/img/pdficon_small.png)
![](/img/pdficon_small.png)
![](/img/pdficon_small.png)
![](/img/pdficon_small.png)
![](/img/pdficon_small.png)
![](/img/pdficon_small.png)
![](/img/pdficon_small.png)
![](/img/pdficon_small.png)